We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
The prostate is a glandular organ present in men and is crossed by the urethra. It is involved in semen formation (80% of its content) and is therefore a sexual organ. When it grows, especially after the age of 50, it results in benign hyperplasia, but there are some symptoms, as the prostatic urethra consequently becomes narrower and thus obstructs the normal passage of urine.
The urethra is the urinary passage that goes from the bladder to the outside. In men, it has two branches; the prostatic urethra (passing through the prostate) and the spongy urethra, which crosses the entire penis to the outside.
When the prostate grows in size (benign prostatic hyperplasia or BPH), the diameter of the urethra decreases and symptoms occur. The obstruction of the urethra by the prostate is progressive and causes repercussions in the bladder, which requires more effort to drain the urine. It can also lead to urinary infections and the formation of lithiasis (stony concretions or calculi) from the salts contained in urine because it is not emptied easily and thus sedimentation of salts takes place.
If the obstruction is very large, the difficulty in removing the urine can cause the kidneys to be damaged because the bladder cannot be emptied properly.
More frequently urinating than normal, urinating at night, loss of force in urine stream, urinary urgency (the patient feels an intense urge to urinate) and also episodes in which urine escapes.
Men over the age of 50, with an increase in incidence as they get older.
Diagnosis is reached through clinical history, where the patient’s symptoms are ascertained, and a rectal touch, where the doctor accesses the prostate to assess the size and any abnormalities. An ultrasound will give information on the kidneys, the size of the prostate and the degree of drainage of the bladder.
A PSA test allows us to investigate suspected prostate cancer.
It is initially based on oral medications that relax the prostate muscles and facilitate the passage and normal evacuation of urine, or others that reduce its volume. In more advanced stages, drainage of the central part of the prostate should be done through a transurethral resection or laser enucleation.
Physical examination, ultrasound, PSA test. Urine flow test and assessment of post-void residual urine
Not applicable. Periodic checks for the onset of symptoms are the key to early diagnosis.
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.